InflaRx (IFRX) Goodwill & Intangibles (2016 - 2026)
InflaRx's (IFRX) quarterly Goodwill & Intangibles came in at $53382.5 in Q1 2026, down 6.26% year-on-year from $56944.8 in Q1 2025, and up 105.93% quarter-over-quarter from -$900132.7 in Q4 2025.
InflaRx (IFRX) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
InflaRx has disclosed Goodwill & Intangibles across 11 years of filings, most recently posting $53382.5 for Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $53382.5, down 6.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $53382.5 (down 6.26% YoY), and the FY2025 annual result was -$900132.7, down 217.66% from the prior year.
- Goodwill & Intangibles came in at $53382.5 for Q1 2026 at InflaRx, up from -$900132.7 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $765021.3 in Q4 2024 to a low of -$900132.7 in Q4 2025.
- The 5-year median for Goodwill & Intangibles is $56944.8 (2025), against an average of $111719.1.
- Across the five-year window, Goodwill & Intangibles surged 2637.14% in 2024 and tumbled 217.66% in 2025, its largest moves.
- InflaRx's Goodwill & Intangibles stood at $737893.9 in 2022, then plunged by 96.21% to $27949.7 in 2023, then soared by 2637.14% to $765021.3 in 2024, then slumped by 217.66% to -$900132.7 in 2025, then surged by 105.93% to $53382.5 in 2026.
- The last three Goodwill & Intangibles figures came in at $53382.5 (Q1 2026), -$900132.7 (Q4 2025), and $53988.1 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,382.49 |
| Dec 31, 2025 | -900,132.73 |
| Sep 30, 2025 | 53,988.13 |
| Jun 30, 2025 | 56,717.97 |
| Mar 31, 2025 | 56,944.82 |
| Dec 31, 2024 | 765,021.34 |
| Sep 30, 2024 | 48,136.06 |
| Jun 30, 2024 | 48,326.41 |
| Mar 31, 2024 | 56,648.33 |
| Dec 31, 2023 | 27,949.69 |
| Sep 30, 2023 | 72,646.00 |
| Jun 30, 2023 | 98,862.36 |
| Mar 31, 2023 | 123,270.09 |
| Dec 31, 2022 | 737,893.91 |
| Sep 30, 2022 | 164,311.41 |
| Jun 30, 2022 | 199,772.22 |
| Mar 31, 2022 | 235,486.66 |
| Dec 31, 2021 | 824,736.71 |
| Sep 30, 2021 | 309,729.20 |
| Jun 30, 2021 | 351,609.93 |